Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myogenic factor 6 (MYF6) is a basic helix-loop-helix (bHLH) transcription factor specifically expressed in skeletal muscle, with a pivotal role in the regulation of muscle differentiation (myogenesis) and muscle regeneration[1][2][3]. It is part of the myogenic regulatory factor (MRF) family, which also includes MYOD1, MYOG, and MYF5. MYF6 is involved in transcriptional activation of a range of muscle-specific genes and has a unique function in regulating myokine expression in muscle fibers, impacting the maintenance of the adult muscle stem cell (satellite cell) pool[2]. Mutations in MYF6 are associated with autosomal dominant centronuclear myopathy and have been linked to various inherited muscle disorders, but no approved drugs currently target MYF6 directly[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myogenic factor 6 (MYF6).